Corify funded by Two Torres Quevedo Programs

We are proud to announce that Corify has been awarded funding from two Torres Quevedo programs, a major recognition of our innovative work and dedication to advancing healthcare technology! 🎉

The Torres Quevedo Program, funded by the Spanish Ministry of Science and Innovation, supports R&D projects by helping companies like ours recruit top research talent. It provides three-year funding for RubĂ©n Molero and Ismael Hernández, Post-doctoral researchers to carry out cutting-edge research and development projects that directly contribute to Spain’s scientific and technological progress.

This funding will allow us to further accelerate our work in non-invasive cardiac mapping, a breakthrough technology designed to improve the diagnosis and treatment of heart conditions. The financial support covers up to 70% of the researcher’s salary, which is a significant boost, allowing us to focus more on innovation and creating a lasting impact on patient care.

Being selected for the Torres Quevedo Program is a huge honor and a testament to Corify’s commitment to excellence in healthcare innovation. We are incredibly proud to be recognized by such a prestigious initiative that values scientific contribution and technological advancement. 🌟 Stay tuned for more updates as we take this exciting journey forward!

Grant PTQ2023-013018 and PTQ2023-012972 funded by MICIU/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR”.

#Innovation #Healthcare #R&D #TorresQuevedo #Funding #Corify #NonInvasiveCardiacMapping #ScienceAndTechnology #HeartHealth

Related posts

đź’ˇ A Step Closer to Making Precision Resynchronization Therapy a Reality for All Patients: Corify at Clinical Guidelines We are proud to...

[Valencia, 28/05/2025] – Corify Care, an AI-driven medical technology company specializing in global cardiac mapping and real-time precision guidance for the treatment...

[Valencia, 28/05/2025] Corify Care, an AI-driven medical technology company specializing in global cardiac mapping and real-time precision guidance for the treatment of...